Why do certain diseases go into remission during pregnancy?

Jun 17, 2010

During pregnancy, many women experience remission of autoimmune diseases like multiple sclerosis and uveitis. Now, scientists have described a biological mechanism responsible for changes in the immune system that helps to explain the remission.

The expression of an enzyme known as pyruvate kinase is reduced in in pregnant women compared to non-pregnant women, according to Howard R. Petty, Ph.D., biophysicist at the University of Michigan Kellogg Eye Center and Roberto Romero, M.D., of the National Institutes for Health. The study, which appears online ahead of print in the August issue of the American Journal of Reproductive Immunology, also reports that expression of the enzyme is lower in pregnant women compared to those with pre-eclampsia, a condition with inflammatory components.

The study is significant because the newly discovered mechanism points to a pathway that could be targeted for treatment. "It may be possible to design drugs that mildly suppress pyruvate kinase activity as a means of replicating the immune status of normal pregnancy," says Petty. In addition to pre-eclampsia, he believes that , , and uveitis may eventually yield to similarly designed drugs.

In his search to explain the phenomenon, Petty knew to look for a metabolic pathway or mechanism with two characteristics. It had to "dial down" the intensity of the normal , an action needed so that a pregnant woman does not reject the fetus, which has proteins from the father that are "foreign" to the mother. At the same time, such a mechanism must support cell growth needed by the developing fetus.

The activity of the enzyme pyruvate kinase—and and its product, pyruvate—fills both roles: promoting cell growth while modifying the immune response. Because pyruvate kinase activity is depressed during pregnancy, supports an increased production of lipids, carbohydrates, , and other substances that support cell growth.

Petty explains that our normal robust immune response depends upon pyruvate to promote calcium signaling, which, in turn, stimulates the production of messenger molecules called cytokines. When pyruvate is decreased during pregnancy, calcium signaling is also reduced, and the immune response is different than that in non-pregnant individuals.

Says Petty, "Modification of signaling along this pathway allows the pregnant woman to maintain an immune response, but at a level that will not harm the fetus."

The study included 21 women in their third trimester of a normal pregnancy, 25 women with pre-eclampsia, and a control group of non-pregnant women. Petty and colleagues used a variety of methods to confirm their findings, including fluorescence microscopy and flow cytometry, which are used to study cell signaling.

The higher levels of the enzyme seen in women with pre-eclampsia bolster the study's findings, says Petty.

"Pre-eclampsia has features of inflammatory disease. If you don't reduce these pyruvate levels, you heighten inflammatory disease," he adds. Petty wonders whether one day enzyme levels could be tested early in pregnancy to predict the likelihood of developing pre-eclampsia or other complications.

It is possible, says Petty, that the general mechanisms described in the current study may apply to more than one complication of pregnancy. This possibility—and that of designing drugs to suppress pyruvate kinase activity—is the focus of future research. "I have a long list of things I'd like to see developed for the clinic in the next five years," adds Petty.

Explore further: Clipping proteins that package genes may limit abnormal cell growth in tumors

More information: Leukocyte Pyruvate Kinase Expression Is Reduced in Normal Human Pregnancy but Not in Pre-eclampsia. Amer J Reprod Immunol, online 6.15.10 at www3.interscience.wiley.com/cg… /123525215/HTMLSTART

add to favorites email to friend print save as pdf

Related Stories

Pre-eclampsia linked to thyroid problems

Nov 18, 2009

Women who develop pre-eclampsia during pregnancy are more likely than other women to have reduced thyroid function (hypothyroidism), finds a study published in BMJ today. It may also put women at a greater risk of thyroi ...

Previous abortions and exercise: Do they affect pregnancy?

Nov 11, 2008

Women who have had two or more induced abortions have a reduced risk of pre-eclampsia by 60 %. It is not currently understood to what degree physical activity during pregnancy protects against pre-eclampsia, compared to previous ...

Pre-eclampsia may be autoimmune disease

Jul 28, 2008

Biochemists at The University of Texas Medical School at Houston say they are the first to provide pre-clinical evidence that pregnancy-induced high blood pressure or pre-eclampsia may be an autoimmune disease. Their research ...

Faithful mothers have healthier babies

Nov 12, 2009

Faculty of 1000 reviewers examine a study from New Zealand on whether prolonged exposure to the father's semen protects new mothers against pre-eclampsia and having an undersized baby.

Breakthrough in pre-eclampsia test

Feb 12, 2008

A team at the University of Leeds has discovered a way of diagnosing pre-eclampsia, a condition which affects almost one in ten pregnant women and accounts for up to 15% of all premature deliveries.

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.